Others

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC20614	A-832234	A-832234 is a potent, selective, reversible MetAP2 inhibitor with IC50 of 19 nM..
DC23183	A-836339	A-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors, displays 425- and 189-fold selectivity over CB1 receptor, respectively.
DC22721	A-943931 dihydrochloride	A-943931 dihydrochloride is a potent, selective antagonist of histamine H4 receptor (H4R) with binding pKi of 8.33 and 8.42 for hH4 and rH4, respectively.
DC22720	A-943931	A-943931 is a potent, selective antagonist of histamine H4 receptor (H4R) with binding pKi of 8.33 and 8.42 for hH4 and rH4, respectively.
DC20616	AA 41612 Featured	AA 41612 is a potent, synthetic melanopsin antagonist with IC50 of 15.8 nM, attenuates melanopsin photocurrent in a dose-dependent manner.
DC23202	JNJ-16259685	aA highly potent, selective, non-competitive and centrally active mGluR1 antagonist with Ki of 0.34 nM.
DC23277	AA-115 Featured	AA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM.
DC21979	ATF6 agonist compound A147 Featured	ATF6 agonist compound A147 is a specific, small molecule agonist of transcription factor ATF6, activates ATF6 and influences differentiation of stem cells.147 has broad antiviral activity against multiple DENV strains and serotypes and that the compound i
DC10165	AA26-9 Featured	AA26-9 is a potent and broad spectrum serine hydrolase inhibitor.
DC20961	AA-861	AA-861 (Docebenone) is a potent, selective 5-Lipoxygenase (5-LO) inhibitor with IC50 of 0.8 uM.
DC26090	AAD777	AAD777 (NVP-AAD777.
DC20618	AAI-101 Featured	AAI-101 is a novel extended-spectrum β-lactamase inhibitor with activity against many β-lactamases, including some class A and class D carbapenemases.
DC12566	AAK1 inhibitor 1	AAK1 inhibitor 1 (SGC-AAK1-1) is a potent, selective inhibitor of AAK1 and BMP2K/BIKE ((BMP-2 inducible kinase)) that potently targets the ATP-binding site (AAK1 Ki =9.1 nM, BIKE Ki= 17 nM).
DC21862	AAK1 inhibitor 25A	AAK1 inhibitor 25A is a potent, selective inhibitor of AAK1 and the closely related kinase BMP2K with Ki of 8 nM (AAK1).
DC12400	AAL(S)	AAL(S) is the chiral deoxy analog of the FDA approved drug FTY720, has been shown to inhibit proliferation and apoptosis in several cancer cell lines by activating protein phosphatase 2A (PP2A)..
DC23864	AAL993 Featured	AAL993 (ZK260253) is a potent, orally active VEGFR inhibitor with IC50 of 130, 23 and 18 nM for VEGFR-1, 2 and 3, respectively.
DC21981	CD73 inhibitor AB-680 Featured	AB680 (AB-680) is a highly potent, selective, reversible inhibitor of CD73 with Ki/IC50 of 4.9/70 pM (hCD73), displays > 10,000-fold selectivity against related ecto-nucleotidases (CD39, NTPDases 2/3/8) and a large panel of unrelated enzymes, receptors, a
DC8161	Xeglyze(Abametapir) Featured	Abametapir is the active ingredient of Xeglyze Lotion.
DC12444	ABD-1970	ABD-1970 (ABD1970) is a highly potent, selective Monoacylglycerol lipase (MGLL) inhibitor with IC50 of 13 nM (human MGLL).
DC20620	ABD345	ABD345 is a small molecule inhibitor of RANKL signalling, inhibits TNF-induced NF-κB and MAPK activation and inflammation.
DC23586	Abeprazan	Abeprazan is an acid pump inhibitor..
DC24211	Abiraterone (D4A) Featured	Abiraterone (D4A) is an active metabolite of the CYP17A1 inhibitor abiraterone.
DC20619	ABL127 Featured	ABL127 (ML174) is a potent, selective, covalent inhibitor of protein methylesterase 1 (PME-1) with IC50 of 10 nM.
DC20298	ABL-IN-29	ABL-IN-29 is a picomolar ABL kinase inhibitor with IC50 of 0.06/0.11 nM for wt ABL and ABL T315I respectively..
DC20299	ABMA	ABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite.
DC21983	Abn-CBD	Abn-CBD (Abnormal Cannabidiol) is a selective agonist of GPR55 receptor with EC50 of 2.5 uM, shows no significant activity against CB1 and CB2 receptors (EC50>30 uM).
DC20625	ABT-072	ABT-072 is a novel, orally bioavailable non-nucleoside HCV NS5B polymerase inhibitor with EC50 of 0.3 nM (GT1b).
DC22258	ABT-080	ABT-080 is a potent FLAP inhibitor that inhibits ionophore-stimulated LTB(4) formation with with IC50 of 20 nM.
DC20626	ABT-089	ABT-089 (Pozanicline) is a potent, selective α4β2 nAChR agonist with Ki of 16 nM.
DC21984	ABT-100	ABT-100 (ABT100) is a highly selective, potent, orally bioavailable inhibitor of farnesyltransferase (FTase).

Others

Customized Consultation X

Your information is safe with us. * Required Fields.